Characteristics of immune cell changes before and after immunotherapy and their clinical significance in patients with unexplained recurrent spontaneous abortion

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 1169-1178

  Gao, L ^a   Zhang, J P ^b   Chen, H ^b   Zhang, S N ^b   Chen, L B ^b   Tan, J P ^b   Liu, M L ^b   Meng, L L ^b   Wang, Y H ^b   Zhang, R ^b   Liu, Y L ^b   Cai, W B ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Immune cell; Unexplained recurrent spontaneous abortion

Indexed keywords

ADULT; ARTICLE; CD4 CD8 RATIO; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PREGNANCY; SPONTANEOUS ABORTION; UNEXPLAINED RECURRENT SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY OUTCOME; T LYMPHOCYTE;

ABORTION, SPONTANEOUS; ADULT; CASE-CONTROL STUDIES; CD4-CD8 RATIO; FEMALE; HUMANS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; PREGNANCY; PREGNANCY OUTCOME; T-LYMPHOCYTES;

EID: 84897557793     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.February.27.1     Document Type: Article

References (27)

1. Adachi H, Takakuwa K, Mitsui T, Ishii K, et al. (2003). Results of immunotherapy for patients with unexplained secondary recurrent abortions. Clin. Immunol. 106: 175-180.
2. Aluvihare VR, Kallikourdis M and Betz AG (2005). Tolerance, suppression and the fetal allograft. J. Mol. Med. 83: 88-96.
3. Bansal AS, Bajardeen B and Thum MY (2012). The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J. Reprod. Immunol. 93: 41-51.
4. Bartha JL, Comino-Delgado R, Martinez-Del FP, Ortega MJ, et al. (2000). Lymphocyte subpopulations after normal pregnancy and spontaneous abortion in primigravidas. J. Reprod. Med. 45: 567-571.
5. Beaman KD, Ntrivalas E, Mallers TM, Jaiswal MK, et al. (2012). Immune etiology of recurrent pregnancy loss and its diagnosis. Am. J. Reprod. Immunol. 67: 319-325.
6. Bulletti C, Flamigni C and Giacomucci E (1996). Reproductive failure due to spontaneous abortion and recurrent miscarriage. Hum. Reprod. Update 2: 118-136.
7. Chen SJ, Liu YL and Sytwu HK (2012). Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation. Clin. Dev. Immunol. 2012: 258391.
8. Christiansen OB, Nielsen HS and Pedersen B (2004). Active or passive immunization in unexplained recurrent miscarriage. J. Reprod. Immunol. 62: 41-52.
9. Danilova N (2012). The evolution of adaptive immunity. Adv. Exp. Med. Biol. 738: 218-235.
10. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J and Oleszczuk J (2002). The immunophenotype of patients with recurrent pregnancy loss. Eur. J. Obstet. Gynecol. Reprod. Biol. 103: 53-57.
11. Guleria I and Sayegh MH (2007). Maternal acceptance of the fetus: true human tolerance. J. Immunol. 178: 3345-3351.
12. Hussein MR, Fathi NA, El-Din AM, Hassan HI, et al. (2008). Alterations of the CD4(+), CD8(+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol. Oncol. Res. 14: 321-328.
13. Jablonowska B, Palfi M, Matthiesen L, Selbing A, et al. (2002). T and B lymphocyte subsets in patients with unexplained recurrent spontaneous abortion: IVIG versus placebo treatment. Am. J. Reprod. Immunol. 48: 312-318.
14. Jin LP, Fan DX and Li DJ (2011). Regulation of costimulatory signal in maternal-fetal immune tolerance. Am. J. Reprod. Immunol. 66: 76-83.
15. Kwak-Kim J, Park JC, Ahn HK, Kim JW, et al. (2010). Immunological modes of pregnancy loss. Am. J. Reprod. Immunol. 63: 611-623.
16. Leber A, Zenclussen ML, Teles A, Brachwitz N, et al. (2011). Pregnancy: tolerance and suppression of immune responses. Methods Mol. Biol. 677: 397-417.
17. Luppi P, Haluszczak C, Trucco M and DeLoia JA (2002). Normal pregnancy is associated with peripheral leukocyte activation. Am. J. Reprod. Immunol. 47: 72-81.
18. Makrydimas G, Plachouras N, Higueras MT, Thilaganathan B, et al. (1994). Maternal peripheral blood lymphocyte subpopulations in normal and pathological pregnancies. Fetal Diagn. Ther. 9: 371-378.
19. Margolick JB, Gange SJ, Detels R, O'Gorman MR, et al. (2006). Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 42: 620-626.
20. Mei S, Tan J, Chen H, Chen Y, et al. (2010). Changes of CD4+CD25high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil. Steril. 94: 2244-2247.
21. Pandey MK and Agrawal S (2004). Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Int. Immunopharmacol. 4: 289-298.
22. Park DW, Lee HJ, Park CW, Hong SR, et al. (2010). Peripheral blood NK cells reflect changes in decidual NK cells in women with recurrent miscarriages. Am. J. Reprod. Immunol. 63: 173-180.
23. Saito S, Nakashima A and Shima T (2011). Future directions of studies for recurrent miscarriage associated with immune etiologies. J. Reprod. Immunol. 90: 91-95.
24. Shankarkumar U, Pradhan VD, Patwardhan MM, Shankarkumar A, et al. (2011). Autoantibody profile and other immunological parameters in recurrent spontaneous abortion patients. Niger. Med. J. 52: 163-166.
25. Stephenson M and Kutteh W (2007). Evaluation and management of recurrent early pregnancy loss. Clin. Obstet. Gynecol. 50: 132-145.
26. Wilczyński JR (2006). Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia-the same basic mechanism? Hum. Immunol. 67: 492-511.
27. Yang KM, Ntrivalas E, Cho HJ, Kim NY, et al. (2010). Women with multiple implantation failures and recurrent pregnancy losses have increased peripheral blood T cell activation. Am. J. Reprod. Immunol. 63: 370-378.